1. 1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA: Cancer J Clin. 2017;67:7-30. doi: 10.3322/caac.21387
2. 2. Ge L, Pan B, Song F, Ma J, Zeraatkar D, Zhou J, et al. Comparing the diagnostic accuracy of five common tumor biomarkers and for a network meta-analysis of diagnostic test accuracy. BMJ Open. 2017;7:e018175. doi: 10.1136/bmjopen-2017-018175
3. 3. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-86. doi: 10.1002/ijc.29210
4. 4. Zhang Y, Yang J, Li H, Wu Y, Zhang H, Chen W. Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis. Int J Clin Exp Med. 2015;8(7):11683-91.
5. 5. Huang J, Liu J, Chen-Xiao K, Zhang X, Lee WN, Go VL, et al. Advance in microRNA as a potential biomarker for early detection of pancreatic cancer. Biomarker Res. 2016;4:20. doi: 10.1186/s40364-016-0074-3